Nanosizing—oral formulation development and biopharmaceutical evaluation

F Kesisoglou, S Panmai, Y Wu - Advanced drug delivery reviews, 2007 - Elsevier
Poor aqueous solubility represents a major hurdle in achieving adequate oral bioavailability
for a large percentage of drug compounds in drug development nowadays. Nanosizing …

Nanosizing--oral formulation development and biopharmaceutical evaluation

F Kesisoglou, S Panmai, Y Wu - Advanced drug delivery …, 2007 - pubmed.ncbi.nlm.nih.gov
Poor aqueous solubility represents a major hurdle in achieving adequate oral bioavailability
for a large percentage of drug compounds in drug development nowadays. Nanosizing …

[引用][C] Nanosizing: Oral formulation development and biopharmaceutical evaluation

F KESISOGLOU, S PANMAI… - Advanced drug delivery …, 2007 - pascal-francis.inist.fr
Nanosizing : Oral formulation development and biopharmaceutical evaluation CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

[引用][C] Nanosizing—Oral formulation development and biopharmaceutical evaluation

F Kesisoglou, S Panmai, Y Wu - Advanced Drug Delivery Reviews, 2007 - cir.nii.ac.jp
Nanosizing — Oral formulation development and biopharmaceutical evaluation | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Nanosizing—Oral formulation development and biopharmaceutical evaluation

F Kesisoglou, S Panmai, Y Wu - Advanced Drug Delivery Reviews, 2007 - infona.pl
Poor aqueous solubility represents a major hurdle in achieving adequate oral bioavailability
for a large percentage of drug compounds in drug development nowadays. Nanosizing …

[引用][C] NANOSIZING-ORAL FORMULATION DEVELOPMENT AND BIOPHARMACEUTICAL EVALUATION

F KESISOGLOU, S PANMAI, Y WU - 2007 - sid.ir

Nanosizing--oral formulation development and biopharmaceutical evaluation.

F Kesisoglou, S Panmai, Y Wu - Advanced Drug Delivery Reviews, 2007 - europepmc.org
Poor aqueous solubility represents a major hurdle in achieving adequate oral bioavailability
for a large percentage of drug compounds in drug development nowadays. Nanosizing …

[PDF][PDF] Nanosizing—Oral formulation development and biopharmaceutical evaluation☆

F Kesisoglou, S Panmai, Y Wu - Advanced Drug Delivery Reviews, 2007 - academia.edu
Poor aqueous solubility represents a major hurdle in achieving adequate oral bioavailability
for a large percentage of drug compounds in drug development nowadays. Nanosizing …

[引用][C] Nanosizing-Oral Formulation Development and Biopharmaceutical Evaluation

F KESISOGLOU - Adv. Drug Delivery Rev., 2007 - cir.nii.ac.jp

[引用][C] Nanosizing: Oral formulation development and biopharmaceutical evaluation

F KESISOGLOU, S PANMAI, WU YUNHUI - Advanced drug delivery …, 2007 - Elsevier